This suggests activation of PPARγ may protect against breast tumour progression only when mammary epithelial-stromal crosstalk contains functional PPARγ signaling in both cell types, and is the focus of additional studies beyond the scope of this work. The gene discussed is PPARG; the disease is breast neoplasm.